Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease.

Emmanouil Korakas Aikaterini KountouriGeorge PavlidisEvangelos OikonomouEmmanouil VrentzosEleni MichalopoulouVasiliki TsigkouKonstantinos KatogiannisLoukia PlioutaKonstantinos BalampanisSotirios PililisKonstantinos Malandris Apostolos Tsapas Gerasimos Siasos Ignatios Ikonomidis Vaia A Lambadiari

Published in: Journal of the Endocrine Society (2024)

Twelve-month treatment with semaglutide simultaneously improves arterial stiffness, endothelial function, and liver steatosis and fibrosis in patients with T2DM and NAFLD.

Keyphrases

insulin resistance
blood pressure
high fat diet
type diabetes
adipose tissue
metabolic syndrome
fatty acid
skeletal muscle
combination therapy
glycemic control